HSBC Holdings’s scPharmaceuticals SCPH Stock Holding History

HSBC Holdings’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,900,042	Closed	-$10.8M	–	3132
2025 Q3	$10.8M	Buy	+1,900,042	New	+$9.73M	0.01%	900

HSBC Holdings's SCPH Position: Q4 2025 in Review

HSBC Holdings sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 1,900,042 shares — an estimated $10.8M sold.

HSBC Holdings first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $10.8M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

HSBC Holdings reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
HSBC Holdings sold 1,900,042 scPharmaceuticals shares in Q4 2025, an estimated $10.8M.
HSBC Holdings first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
HSBC Holdings's scPharmaceuticals position peaked at $10.8M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.